Literature DB >> 23535732

Identification of 23 new prostate cancer susceptibility loci using the iCOGS custom genotyping array.

Rosalind A Eeles1, Ali Amin Al Olama, Sara Benlloch, Edward J Saunders, Daniel A Leongamornlert, Malgorzata Tymrakiewicz, Maya Ghoussaini, Craig Luccarini, Joe Dennis, Sarah Jugurnauth-Little, Tokhir Dadaev, David E Neal, Freddie C Hamdy, Jenny L Donovan, Ken Muir, Graham G Giles, Gianluca Severi, Fredrik Wiklund, Henrik Gronberg, Christopher A Haiman, Fredrick Schumacher, Brian E Henderson, Loic Le Marchand, Sara Lindstrom, Peter Kraft, David J Hunter, Susan Gapstur, Stephen J Chanock, Sonja I Berndt, Demetrius Albanes, Gerald Andriole, Johanna Schleutker, Maren Weischer, Federico Canzian, Elio Riboli, Tim J Key, Ruth C Travis, Daniele Campa, Sue A Ingles, Esther M John, Richard B Hayes, Paul D P Pharoah, Nora Pashayan, Kay-Tee Khaw, Janet L Stanford, Elaine A Ostrander, Lisa B Signorello, Stephen N Thibodeau, Dan Schaid, Christiane Maier, Walther Vogel, Adam S Kibel, Cezary Cybulski, Jan Lubinski, Lisa Cannon-Albright, Hermann Brenner, Jong Y Park, Radka Kaneva, Jyotsna Batra, Amanda B Spurdle, Judith A Clements, Manuel R Teixeira, Ed Dicks, Andrew Lee, Alison M Dunning, Caroline Baynes, Don Conroy, Melanie J Maranian, Shahana Ahmed, Koveela Govindasami, Michelle Guy, Rosemary A Wilkinson, Emma J Sawyer, Angela Morgan, David P Dearnaley, Alan Horwich, Robert A Huddart, Vincent S Khoo, Christopher C Parker, Nicholas J Van As, Christopher J Woodhouse, Alan Thompson, Tim Dudderidge, Chris Ogden, Colin S Cooper, Artitaya Lophatananon, Angela Cox, Melissa C Southey, John L Hopper, Dallas R English, Markus Aly, Jan Adolfsson, Jiangfeng Xu, Siqun L Zheng, Meredith Yeager, Rudolf Kaaks, W Ryan Diver, Mia M Gaudet, Mariana C Stern, Roman Corral, Amit D Joshi, Ahva Shahabi, Tiina Wahlfors, Teuvo L J Tammela, Anssi Auvinen, Jarmo Virtamo, Peter Klarskov, Børge G Nordestgaard, M Andreas Røder, Sune F Nielsen, Stig E Bojesen, Afshan Siddiq, Liesel M Fitzgerald, Suzanne Kolb, Erika M Kwon, Danielle M Karyadi, William J Blot, Wei Zheng, Qiuyin Cai, Shannon K McDonnell, Antje E Rinckleb, Bettina Drake, Graham Colditz, Dominika Wokolorczyk, Robert A Stephenson, Craig Teerlink, Heiko Muller, Dietrich Rothenbacher, Thomas A Sellers, Hui-Yi Lin, Chavdar Slavov, Vanio Mitev, Felicity Lose, Srilakshmi Srinivasan, Sofia Maia, Paula Paulo, Ethan Lange, Kathleen A Cooney, Antonis C Antoniou, Daniel Vincent, François Bacot, Daniel C Tessier, Zsofia Kote-Jarai, Douglas F Easton.   

Abstract

Prostate cancer is the most frequently diagnosed cancer in males in developed countries. To identify common prostate cancer susceptibility alleles, we genotyped 211,155 SNPs on a custom Illumina array (iCOGS) in blood DNA from 25,074 prostate cancer cases and 24,272 controls from the international PRACTICAL Consortium. Twenty-three new prostate cancer susceptibility loci were identified at genome-wide significance (P < 5 × 10(-8)). More than 70 prostate cancer susceptibility loci, explaining ∼30% of the familial risk for this disease, have now been identified. On the basis of combined risks conferred by the new and previously known risk loci, the top 1% of the risk distribution has a 4.7-fold higher risk than the average of the population being profiled. These results will facilitate population risk stratification for clinical studies.

Entities:  

Mesh:

Year:  2013        PMID: 23535732      PMCID: PMC3832790          DOI: 10.1038/ng.2560

Source DB:  PubMed          Journal:  Nat Genet        ISSN: 1061-4036            Impact factor:   38.330


  37 in total

1.  GenoSNP: a variational Bayes within-sample SNP genotyping algorithm that does not require a reference population.

Authors:  Eleni Giannoulatou; Christopher Yau; Stefano Colella; Jiannis Ragoussis; Christopher C Holmes
Journal:  Bioinformatics       Date:  2008-07-24       Impact factor: 6.937

2.  Genome-wide association study in Chinese men identifies two new prostate cancer risk loci at 9q31.2 and 19q13.4.

Authors:  Jianfeng Xu; Zengnan Mo; Dingwei Ye; Meilin Wang; Fang Liu; Guangfu Jin; Chuanliang Xu; Xiang Wang; Qiang Shao; Zhiwen Chen; Zhihua Tao; Jun Qi; Fangjian Zhou; Zhong Wang; Yaowen Fu; Dalin He; Qiang Wei; Jianming Guo; Denglong Wu; Xin Gao; Jianlin Yuan; Gongxian Wang; Yong Xu; Guozeng Wang; Haijun Yao; Pei Dong; Yang Jiao; Mo Shen; Jin Yang; Jun Ou-Yang; Haowen Jiang; Yao Zhu; Shancheng Ren; Zhengdong Zhang; Changjun Yin; Xu Gao; Bo Dai; Zhibin Hu; Yajun Yang; Qijun Wu; Hongyan Chen; Peng Peng; Ying Zheng; Xiaodong Zheng; Yongbing Xiang; Jirong Long; Jian Gong; Rong Na; Xiaoling Lin; Hongjie Yu; Zhong Wang; Sha Tao; Junjie Feng; Jishan Sun; Wennuan Liu; Ann Hsing; Jianyu Rao; Qiang Ding; Fredirik Wiklund; Henrik Gronberg; Xiao-Ou Shu; Wei Zheng; Hongbing Shen; Li Jin; Rong Shi; Daru Lu; Xuejun Zhang; Jielin Sun; S Lilly Zheng; Yinghao Sun
Journal:  Nat Genet       Date:  2012-09-30       Impact factor: 38.330

3.  A risk prediction algorithm based on family history and common genetic variants: application to prostate cancer with potential clinical impact.

Authors:  Robert J Macinnis; Antonis C Antoniou; Rosalind A Eeles; Gianluca Severi; Ali Amin Al Olama; Lesley McGuffog; Zsofia Kote-Jarai; Michelle Guy; Lynne T O'Brien; Amanda L Hall; Rosemary A Wilkinson; Emma Sawyer; Audrey T Ardern-Jones; David P Dearnaley; Alan Horwich; Vincent S Khoo; Christopher C Parker; Robert A Huddart; Nicholas Van As; Margaret R McCredie; Dallas R English; Graham G Giles; John L Hopper; Douglas F Easton
Journal:  Genet Epidemiol       Date:  2011-07-18       Impact factor: 2.135

4.  Single-nucleotide polymorphisms in p53 pathway and aggressiveness of prostate cancer in a Caucasian population.

Authors:  Tong Sun; Gwo-Shu Mary Lee; William K Oh; Mark Pomerantz; Ming Yang; Wanling Xie; Matthew L Freedman; Philip W Kantoff
Journal:  Clin Cancer Res       Date:  2010-09-20       Impact factor: 12.531

5.  An illegitimate microRNA target site within the 3' UTR of MDM4 affects ovarian cancer progression and chemosensitivity.

Authors:  Jessika Wynendaele; Anja Böhnke; Eleonora Leucci; Søren Jensby Nielsen; Irina Lambertz; Stefanie Hammer; Nadja Sbrzesny; Dana Kubitza; Anja Wolf; Elise Gradhand; Katharina Balschun; Ioana Braicu; Jalid Sehouli; Silvia Darb-Esfahani; Carsten Denkert; Christoph Thomssen; Steffen Hauptmann; Anders Lund; Jean-Christophe Marine; Frank Bartel
Journal:  Cancer Res       Date:  2010-11-16       Impact factor: 12.701

6.  Genome-wide association and replication studies identify four variants associated with prostate cancer susceptibility.

Authors:  Julius Gudmundsson; Patrick Sulem; Daniel F Gudbjartsson; Thorarinn Blondal; Arnaldur Gylfason; Bjarni A Agnarsson; Kristrun R Benediktsdottir; Droplaug N Magnusdottir; Gudbjorg Orlygsdottir; Margret Jakobsdottir; Simon N Stacey; Asgeir Sigurdsson; Tiina Wahlfors; Teuvo Tammela; Joan P Breyer; Kate M McReynolds; Kevin M Bradley; Berta Saez; Javier Godino; Sebastian Navarrete; Fernando Fuertes; Laura Murillo; Eduardo Polo; Katja K Aben; Inge M van Oort; Brian K Suarez; Brian T Helfand; Donghui Kan; Carlo Zanon; Michael L Frigge; Kristleifur Kristjansson; Jeffrey R Gulcher; Gudmundur V Einarsson; Eirikur Jonsson; William J Catalona; Jose I Mayordomo; Lambertus A Kiemeney; Jeffrey R Smith; Johanna Schleutker; Rosa B Barkardottir; Augustine Kong; Unnur Thorsteinsdottir; Thorunn Rafnar; Kari Stefansson
Journal:  Nat Genet       Date:  2009-09-20       Impact factor: 38.330

7.  The homeodomain protein HOXB13 regulates the cellular response to androgens.

Authors:  John D Norris; Ching-Yi Chang; Bryan M Wittmann; Rebecca S Kunder; Huaxia Cui; Daju Fan; James D Joseph; Donald P McDonnell
Journal:  Mol Cell       Date:  2009-11-13       Impact factor: 17.970

8.  A multistage genome-wide association study in breast cancer identifies two new risk alleles at 1p11.2 and 14q24.1 (RAD51L1).

Authors:  Gilles Thomas; Kevin B Jacobs; Peter Kraft; Meredith Yeager; Sholom Wacholder; David G Cox; Susan E Hankinson; Amy Hutchinson; Zhaoming Wang; Kai Yu; Nilanjan Chatterjee; Montserrat Garcia-Closas; Jesus Gonzalez-Bosquet; Ludmila Prokunina-Olsson; Nick Orr; Walter C Willett; Graham A Colditz; Regina G Ziegler; Christine D Berg; Saundra S Buys; Catherine A McCarty; Heather Spencer Feigelson; Eugenia E Calle; Michael J Thun; Ryan Diver; Ross Prentice; Rebecca Jackson; Charles Kooperberg; Rowan Chlebowski; Jolanta Lissowska; Beata Peplonska; Louise A Brinton; Alice Sigurdson; Michele Doody; Parveen Bhatti; Bruce H Alexander; Julie Buring; I-Min Lee; Lars J Vatten; Kristian Hveem; Merethe Kumle; Richard B Hayes; Margaret Tucker; Daniela S Gerhard; Joseph F Fraumeni; Robert N Hoover; Stephen J Chanock; David J Hunter
Journal:  Nat Genet       Date:  2009-03-29       Impact factor: 38.330

9.  Genome-wide association study of prostate cancer in men of African ancestry identifies a susceptibility locus at 17q21.

Authors:  Christopher A Haiman; Gary K Chen; William J Blot; Sara S Strom; Sonja I Berndt; Rick A Kittles; Benjamin A Rybicki; William B Isaacs; Sue A Ingles; Janet L Stanford; W Ryan Diver; John S Witte; Ann W Hsing; Barbara Nemesure; Timothy R Rebbeck; Kathleen A Cooney; Jianfeng Xu; Adam S Kibel; Jennifer J Hu; Esther M John; Serigne M Gueye; Stephen Watya; Lisa B Signorello; Richard B Hayes; Zhaoming Wang; Edward Yeboah; Yao Tettey; Qiuyin Cai; Suzanne Kolb; Elaine A Ostrander; Charnita Zeigler-Johnson; Yuko Yamamura; Christine Neslund-Dudas; Jennifer Haslag-Minoff; William Wu; Venetta Thomas; Glenn O Allen; Adam Murphy; Bao-Li Chang; S Lilly Zheng; M Cristina Leske; Suh-Yuh Wu; Anna M Ray; Anselm J M Hennis; Michael J Thun; John Carpten; Graham Casey; Erin N Carter; Edder R Duarte; Lucy Y Xia; Xin Sheng; Peggy Wan; Loreall C Pooler; Iona Cheng; Kristine R Monroe; Fredrick Schumacher; Loic Le Marchand; Laurence N Kolonel; Stephen J Chanock; David Van Den Berg; Daniel O Stram; Brian E Henderson
Journal:  Nat Genet       Date:  2011-05-22       Impact factor: 38.330

10.  Identification of a novel prostate cancer susceptibility variant in the KLK3 gene transcript.

Authors:  Z Kote-Jarai; A Amin Al Olama; D Leongamornlert; M Tymrakiewicz; E Saunders; M Guy; G G Giles; G Severi; M Southey; J L Hopper; K C Sit; J M Harris; J Batra; A B Spurdle; J A Clements; F Hamdy; D Neal; J Donovan; K Muir; P D P Pharoah; S J Chanock; N Brown; S Benlloch; E Castro; N Mahmud; L O'Brien; A Hall; E Sawyer; R Wilkinson; D F Easton; R A Eeles
Journal:  Hum Genet       Date:  2011-04-05       Impact factor: 4.132

View more
  269 in total

1.  Assessing the Cumulative Contribution of New and Established Common Genetic Risk Factors to Early-Onset Prostate Cancer.

Authors:  Ethan M Lange; Jessica V Ribado; Kimberly A Zuhlke; Anna M Johnson; Gregory R Keele; Jin Li; Yunfei Wang; Qing Duan; Ge Li; Zhengrong Gao; Yun Li; Jianfeng Xu; S Lilly Zheng; Kathleen A Cooney
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2015-12-15       Impact factor: 4.254

2.  Association of KLK3, VAMP8 and MDM4 Genetic Variants within microRNA Binding Sites with Prostate Cancer: Evidence from Serbian Population.

Authors:  Nevena Kotarac; Zorana Dobrijevic; Suzana Matijasevic; Dusanka Savic-Pavicevic; Goran Brajuskovic
Journal:  Pathol Oncol Res       Date:  2020-06-17       Impact factor: 3.201

Review 3.  Genome-Wide Association Studies of Cancer in Diverse Populations.

Authors:  Sungshim L Park; Iona Cheng; Christopher A Haiman
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2017-06-21       Impact factor: 4.254

4.  A systematic review of cancer GWAS and candidate gene meta-analyses reveals limited overlap but similar effect sizes.

Authors:  Christine Q Chang; Ajay Yesupriya; Jessica L Rowell; Camilla B Pimentel; Melinda Clyne; Marta Gwinn; Muin J Khoury; Anja Wulf; Sheri D Schully
Journal:  Eur J Hum Genet       Date:  2013-07-24       Impact factor: 4.246

Review 5.  The Prediction of Radiotherapy Toxicity Using Single Nucleotide Polymorphism-Based Models: A Step Toward Prevention.

Authors:  Sarah L Kerns; Suman Kundu; Jung Hun Oh; Sandeep K Singhal; Michelle Janelsins; Lois B Travis; Joseph O Deasy; A Cecile J E Janssens; Harry Ostrer; Matthew Parliament; Nawaid Usmani; Barry S Rosenstein
Journal:  Semin Radiat Oncol       Date:  2015-05-15       Impact factor: 5.934

6.  The heritability of prostate cancer in the Nordic Twin Study of Cancer.

Authors:  Jacob B Hjelmborg; Thomas Scheike; Klaus Holst; Axel Skytthe; Kathryn L Penney; Rebecca E Graff; Eero Pukkala; Kaare Christensen; Hans-Olov Adami; Niels V Holm; Elizabeth Nuttall; Steinbjorn Hansen; Mikael Hartman; Kamila Czene; Jennifer R Harris; Jaakko Kaprio; Lorelei A Mucci
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2014-05-08       Impact factor: 4.254

7.  Prostate cancer incidence as an iceberg.

Authors:  Lorelei A Mucci; Claire H Pernar; Sam Peisch; Travis Gerke; Kathryn M Wilson
Journal:  Eur J Epidemiol       Date:  2017-05-30       Impact factor: 8.082

8.  Prostate cancer screening characteristics in men with BRCA1/2 mutations attending a high-risk prevention clinic.

Authors:  Richard Walker; Alyssa Louis; Alejandro Berlin; Sheri Horsburgh; Robert G Bristow; John Trachtenberg
Journal:  Can Urol Assoc J       Date:  2014-11       Impact factor: 1.862

9.  Gene regulatory mechanisms underpinning prostate cancer susceptibility.

Authors:  Thomas Whitington; Ping Gao; Wei Song; Helen Ross-Adams; Alastair D Lamb; Yuehong Yang; Ilaria Svezia; Daniel Klevebring; Ian G Mills; Robert Karlsson; Silvia Halim; Mark J Dunning; Lars Egevad; Anne Y Warren; David E Neal; Henrik Grönberg; Johan Lindberg; Gong-Hong Wei; Fredrik Wiklund
Journal:  Nat Genet       Date:  2016-03-07       Impact factor: 38.330

10.  Association of Common Susceptibility Variants of Pancreatic Cancer in Higher-Risk Patients: A PACGENE Study.

Authors:  Erica J Childs; Kari G Chaffee; Steven Gallinger; Sapna Syngal; Ann G Schwartz; Michele L Cote; Melissa L Bondy; Ralph H Hruban; Stephen J Chanock; Robert N Hoover; Charles S Fuchs; David N Rider; Laufey T Amundadottir; Rachael Stolzenberg-Solomon; Brian M Wolpin; Harvey A Risch; Michael G Goggins; Gloria M Petersen; Alison P Klein
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2016-05-16       Impact factor: 4.254

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.